Rechercher
image du produit
American Journal of Obstetrics and Gynecology

S'abonner

POSTER SESSION V Saturday, February 10, 2001, 10:00 am – Noon - 03/09/11

Doi : 10.1016/S0002-9378(01)80052-1 
Le texte complet de cet article est disponible en PDF.
Le texte complet de cet article est disponible en PDF.

Plan

0548 EPIDURAL ANALGESIA IS ASSOCIATED WITH AN INCREASED RISK OF REPEATED CESAREAN SECTION
0549 EPIDURAL ANALGESIA IN TWIN GESTATION IS ASSOCIATED WITH ADVERSE OBSTETRICAL OUTCOME
0550 OBSTETRICAL RISK FACTORS AND PREGNANCY OUTCOME OF PLACENTA PREVIA
0551 CLINICAL RISK FACTORS AND PREGNANCY OUTCOME OF PRETERM PLACENTAL ABRUPTION
0552 INFERTILITY TREATMENT IS AN INDEPENDENT RISK FACTOR FOR CESAREAN SECTION AMONG NULLIPAROUS WOMEN AGED 40 AND OLDER
0553 FAILED VACUUM EXTRACTION: MATERNAL RISK FACTORS AND PREGNANCY OUTCOME
0554 FETAL HYDROFLOTATION: A NOVEL TECHNIQUE FOR FACILITATING EXTERNAL CEPHALIC VERSION
0555 INCREASED GESTATIONAL DURATION: RESULTS OF A RANDOMIZED CLINICAL TRIAL TO REDUCE ANTENATAL DRINKING
0556 PROSPECTIVE RANDOMIZED TRIAL OF ONCE VERSUS TWICE A DAY METRONIDAZOLE-VAGINAL IN OBSTETRICAL POPULATION IDENTIFIED WITH BACTERIAL VAGINOSIS
0557 PFANNESTIEL OR JOEL-COHEN INCISION AT CESAREAN DELIVERY: A RANDOMIZED CLINICAL TRIAL
0558 DOES A SINGLE PRENATAL CARE VISIT IMPROVE PERINATAL OUTCOMES?
0559 PATIENT PERCEPTIONS OF MULTIPLE GESTATIONS: AN ASSESSMENT OF KNOWLEDGE AND RISK AVERSION
0560 IS OBSTETRICS AND GYNECOLOGY SONOGRAPHY ESSENTIAL AT A FIELD HOSPITAL SETUP? THOUGHTS AFTER THE EARTHQUAKE—TURKEY, 1999
0561 CLINICAL IMPLICATIONS OF VELAMENTOUS CORD INSERTION IN TRIPLET GESTATIONS
0562 VBAC SCORE <4: SHOULD THEY LABOR?
0563 COMPARISON OF TRIPLET OUTCOMES MANAGED BY MATERNAL FETAL MEDICINE VERSUS COMMUNITY PHYSICIANS
0564 DOES PROLONGED PREGNANCY PREDICT ADVERSE PERINATAL OUTCOME?
0565 MALE GENDER IS AN ETIOLOGY FOR POSTDATES PREGNANCY
0566 SCREENING FOR TYPE; TRANSFUSIONS IN PREGNANCY
0567 THE PERINATAL AND ECONOMIC IMPACT OF PUBLIC FUNDING OF PRENATAL CARE
0568 TWIN DISCORDANCE WITH OR WITHOUT INTRAUTERINE GROWTH RESTRICTION (IUGR): PERINATAL OUTCOME
0569 TIMELY DETECTION OF UTERINE RUPTURE DURING VBAC
0570 PRENATAL DRUG EXPOSURE AND GROWTH TO AGE 7
0571 ANESTHESIA OPTIONS FOR TRIPLET DELIVERIES
0572 COMPARISON OF CERVICAL COLLAGEN IN WOMEN WITH INCOMPETENT CERVIX VERSUS WOMEN WITH COMPETENT CERVIX WITH AND WITHOUT LABOR
0573 BREECH PRESENTING TWINS: IS VAGINAL DELIVERY SAFE?
0574 COMPARISON OF THE PERINATAL MORBIDITY AND MORTALITY OF THE PRESENTING TWIN TO ITS CO-TWIN
0575 THE OUTCOME OF VAGINALLY DELIVERED TWIN GESTATIONS WITH LARGER BIRTH WEIGHT IN TWIN B
0576 OPERATIVE DELIVERY IN TWINS
0577 MODE OF DELIVERY OF SINGLETON BREECH: 11-YEAR EXPERIENCE AT A SINGLE CENTER
0578 DIURNAL PATTERNS OF UTERINE CONTRACTIONS PRIOR TO PRETERM LABOR
0579 THE NEONATAL CONSEQUENCES OF SINGLETON DELIVERY AT 33 THROUGH 36 WEEKS’ GESTATION
0580 IS THERE AN ADVANTAGE TO EARLY DELIVERY IN MONOAMNIOTIC TWIN GESTATIONS?
0581 INTERPREGNANCY INTERVAL IN ADOLESCENTS—EFFECT OF POSTPARTUM CHOICE OF CONTRACEPTION
0582 PLACENTAL HISTOLOGY AND INVASIVENESS OF NEONATAL GROUP B STREPTOCOCCUS
0583 SUBLINGUAL NITROGLYCERIN AS TOCOLYTIC IN EXTERNAL CEPHALIC VERSION: A COMPARATIVE STUDY
0584 ANTENATAL MAGNESIUM EXPOSURE AND NEONATAL DEMISE
0585 PAINLESS VS SYMPTOMATIC PRIOR SECOND-TRIMESTER LOSS: WHICH IS MORE PREDICTIVE OF SUBSEQUENT PRETERM DELIVERY?
0586 PREVALENCE OF ABNORMAL KARYOTYPES IN FIRST- OR SECOND-TRIMESTER LOSSES
0587 NEONATAL OUTCOME OF DISCORDANT TWIN GESTATIONS
0588 TWELVE-YEAR EXPERIENCE OF QUADRUPLET PREGNANCIES AT A SINGLE INSTITUTION
0589 MATERNAL MORBIDITY AND OBSTETRICAL COMPLICATIONS OF QUADRUPLET PREGNANCY: TWELVE-YEAR EXPERIENCE AT A SINGLE INSTITUTION
0590 NEONATAL OUTCOMES OF QUADRUPLET PREGNANCIES: TWELVE-YEAR EXPERIENCE AT A SINGLE INSTITUTION
0591 PRETERM LABOR COMPLICATING QUADRUPLET PREGNANCY: TWELVE-YEAR EXPERIENCE AT A SINGLE INSTITUTION
0592 OBSTETRIC ANTECEDENTS TO INFANTS DELIVERED WITH AN APGAR SCORE OF 0 AT 1 MINUTE
0593 MANAGEMENT OF PREGNANCY AT 23 WEEKS’ GESTATION: CURRENT PRACTICE PATTERNS AMONG PERINATOLOGISTS
0594 CORRECTED MATERNAL WEIGHT GAIN DURING PREGNANCY IS NOT ASSOCIATED WITH FETAL MACROSOMIA
0595 FETAL HEAD POSITIONING DURING THE ACTIVE PHASE OF LABOR: CORRELATION BETWEEN TRANSVAGINAL DIGITAL EXAMINATION AND TRANSABDOMINAL ULTRASOUND ASSESSMENT
0596 VELAMENTOUS CORD INSERTION AS A PROGNOSTIC FACTOR IN TWIN GESTATIONS
0597 VELAMENTOUS CORD INSERTION AS AN ETIOLOGIC AND PROGNOSTIC FACTOR IN TWIN-TWIN TRANSFUSION SYNDROME
0598 RESPIRATORY MORBIDITY OF WELL-DATED TWINS AFTER 35 WEEKS: WHAT ARE THE RISKS OF ELECTIVE DELIVERY?
0599 ANTENATAL STEROIDS IN TRIPLET PREGNANCIES
0600 Withdrawn
0601 IMPACT OF METHOD OF CONCEPTION; SPONTANEOUS VS IN VITRO FERTILIZATION/INTRACYTOPLASMIC SPERM INJECTION ON PERINATAL AND NEONATAL OUTCOMES IN TRIPLET PREGNANCIES
0602 OUTCOMES OF DICHORIONIC TRIPLET PREGNANCIES
0603 TOXIC TRACE ELEMENTS (TE) CAN BE FOUND IN THE MATERNAL AND FETAL COMPARTMENTS
0604 THE INTRAVENOUS FORMATION OF THE DEVELOPING PLACENTAL BASAL PLATE TISSUE INVOLVES BOTH MATERNAL PROTEINS AND FETAL ONCOFETAL FIBRONECTIN
0605 REVIEW OF MONOAMNIOTIC GESTATIONS REPORTED IN THE ENGLISH LANGUAGE LITERATURE FROM 1988 TO 1999
0606 NORMAL PROGRESSION OF THE TDxFLM II ASSAY IN THE LATE THIRD TRIMESTER
0607 THE EFFECT OF MODE OF DELIVERY AND INCREASING LENGTH OF GESTATION ON NEONATAL MORBIDITY IN TWINS
0608 THE RISK OF FETAL DEATH IN MULTIPLE PREGNANCY: THE ROLE OF GESTATIONAL AGE
0609 NEONATAL MORBIDITIES IN TERM TWIN PREGNANCIES: THE EFFECT OF ZYGOSITY
0610 PRENATAL INTERVENTIONS TO IMPROVE OUTCOMES IN TWIN PREGNANCIES
0611 THE MENTAL AND MOTOR DEVELOPMENT OF TWIN CHILDREN: THE ROLE OF ZYGOSITY
0612 TWINS: CERCLAGE OR NO CERCLAGE?
0613 RISK FACTORS FOR PLACENTA ACCRETA IN NULLIPAROUS PATIENTS
0614 FACTORS INFLUENCING COMBINED VAGINAL-CESAREAN SECTION DELIVERY OF TWIN PREGNANCIES
0615 OUTCOME OF TWIN GESTATIONS: HISPANIC VS NON-HISPANIC WOMEN
0616 ESTIMATION OF GESTATIONAL AGE IN THE THIRD TRIMESTER WITH TRANSVERSE CEREBELLAR DIAMETER
0617 DISCORDANT TWIN GROWTH: THE EFFECTIVENESS OF PRENATAL ULTRASOUND SCANNING AS A SCREENING TOOL
0618 DIFFERING DOSE-RESPONSE OF PRENATAL ALCOHOL EXPOSURE FOR BEHAVIORAL OUTCOMES AT AGE 6 TO 7
0619 RISK OF SECOND-TRIMESTER SPONTANEOUS ABORTION IN TRIPLETS
0620 RISK FACTORS FOR SMALL–FOR–GESTATIONAL AGE BIRTHS BETWEEN BLACK AND WHITE ADOLESCENTS IN THE UNITED STATES
0621 ABNORMAL CORD INSERTIONS IN TWIN PREGNANCIES: ASSISTED REPRODUCTION VS SPONTANEOUS CONCEPTION
0622 PREOPERATIVE VAGINAL PREPARATION WITH POVIDONE-IODINE DECREASES THE RISK OF POST-CESAREAN ENDOMETRITIS
0623 SUICIDE ATTEMPTS DURING PREGNANCY BY POISONING: REPORT FROM A NATIONAL DATABASE—1999
0624 ETHNICITY-SPECIFIC NORMS FOR FETAL CROWN-RUMP LENGTH
0625 CESAREAN SECTION FOR CPD IN THE SECOND STAGE OF LABOR
0626 INCREASED RISK FOR CESAREAN DELIVERY AFTER A TRIAL OF LABOR WITH ADVANCING MATERNAL AGE: CESAREAN INDICATIONS AND ROLE OF INDUCTION
0627 TRIAL OF LABOR COMPARED WITH ELECTIVE REPEAT CESAREAN SECTION IN TWIN GESTATIONS WITH PREVIOUS CESAREAN DELIVERY
0628 SPONTANEOUS VERSUS INDUCED LABOR WITH A PREVIOUS CESAREAN SECTION
0629 OUTCOMES OF TRIAL OF LABOR AFTER PREVIOUS CESAREAN AMONG WOMEN WITH FETUSES >4000 GRAMS (MACROSOMIC FETUSES)
0630 CESAREAN SECTION ON MATERNAL REQUEST: A FOUR-YEAR EXPERIENCE
0631 ELECTIVE REPEAT CESAREAN SECTION AND FAILED VAGINAL BIRTH AFTER CESAREAN SECTION HAVE THE SAME INCREASED RISK FOR MAJOR OPERATIVE INJURIES
0632 TEACHING FORCEPS: THE IMPACT OF PROACTIVE FACULTY
0633 REDUCED MATERNAL MORBIDITY WITH ROTATIONAL KEILLAND FORCEPS DELIVERY FROM THE OCCIPUT POSTERIOR POSITION
0634 REGIONAL MANAGEMENT OF THE VLBW (≤1500 GRAM) IN BREECH PRESENTATION
0635 REGIONAL MANAGEMENT OF THE VLBW (≤1500 GRAM) IN CEPHALIC PRESENTATION
0636 DOES UTERINE WIPING INFLUENCE THE RATE OF POST CESAREAN ENDOMETRITIS?
0637 ANTEPARTUM, INTRAPARTUM, AND NEONATAL SIGNIFICANCE OF EXERCISE ON HEALTHY, LOW-RISK PREGNANT WOMEN
0638 WHAT ARE THE RISK FACTORS FOR A BIRTH INJURY DIAGNOSED AFTER A CESAREAN DELIVERY?
0639 MATERNAL AGE AS A PREDICTOR OF SYMPTOMATIC UTERINE RUPTURE DURING A TRIAL OF LABOR AFTER PRIOR CESAREAN DELIVERY
0640 POSTCESAREAN FEVER AND UTERINE RUPTURE IN A SUBSEQUENT TRIAL OF LABOR
0641 Withdrawn
0642 ELECTIVE REPEAT CESAREN SECTION: CAN IT COST LESS THAN A TRIAL OF LABOR?
0643 VAGINAL DELIVERY OF SECOND NONVERTEX TWIN—A SAFE OPTION
0644 ASSOCIATION BETWEEN MAGNESIUM AND INTRAVENTRICULAR HEMORRHAGE
0645 MAGNESIUM SULFATE IS NO MORE EFFICACIOUS THAN OTHER TOCOLYTIC AGENTS
0646 A PROSPECTIVE EVALUATION OF FETAL LACERATION INJURY AT DELIVERY
0647 DETERMINANTS OF PERINATAL MORBIDITY AND DEATH AMONG THE SECOND OF TWINS
0648 ADNEXAL MASSES IN PREGNANCY: MATERNAL AND FETAL IMPLICATIONS
0649 SERUM BILE ACIDS AS AN INDICATOR OF INTRAHEPATIC CHOLESTASIS OF PREGNANCY
0650 GENETIC THROMBOPHILIA AND THROMBOEMBOLIC COMPLICATIONS
0651 LONGITUDINAL STUDY OF THE EFFECT OF HEPARIN DURING PREGNANCY ON BONE MINERAL DENSITY AND BONE MARKERS
0652 PREGNANCY OUTCOME AFTER LOOP ELECTROSURGICAL EXCISION PROCEDURE OF THE CERVIX
0653 ASSOCIATIONS OF PULMONARY EDEMA IN PATIENTS DELIVERING PREMATURELY
0654 INFLUENCE OF PRIOR PREGNANCIES ON DISEASE COURSE AND MORTALITY IN SYSTEMIC SCLEROSIS
0655 THE MATERNAL-FETAL MEDICINE/CRITICAL CARE TEAM: ITS IMPACT ON OTHER SPECIALTY CONSULTATIONS DURING OBSTETRIC INTENSIVE CARE UNIT ADMISSIONS
0656 NEPHROLITHIASIS AND URETEROLITHIASIS IN PREGNANCY: TRIMESTER OF OCCURRENCE, MANAGEMENT, AND TECHNIQUE OF DIAGNOSIS
0657 MECHANICAL VENTILATION AND CESAREAN SECTION IN A CRITICALLY ILL OBSTETRIC POPULATION: AN EXTREMELY GRAVE PROGNOSTIC FACTOR
0658 THE COST-EFFECTIVENESS OF INTERMITTENT PNEUMATIC COMPRESSION FOR THROMBOPROPHYLAXIS AT THE TIME OF CESAREAN DELIVERY
0659 TREATMENT REGIMEN IS MORE PREDICTIVE OF ASTHMA SEVERITY DURING PREGNANCY THAN CURRENT NAEP CRITERIA
0660 THE PROGNOSTIC IMPLICATIONS OF HELICOBACTER PYLORI SEROPOSITIVITY IN PATIENTS WITH HYPEREMESIS GRAVIDARUM
0661 VENOUS THROMBOEMBOLISM AND ASSOCIATED THROMBOPHILIAS IN PREGNANCY
0662 ARTHROPOD ENVENOMATIONS DURING PREGNANCY: REPORT FROM A NATIONAL DATABASE—1999
0663 THE EFFECTS OF GESTATIONAL AGE AND POSITION ON PEAK EXPIRATORY FLOW RATE: A LONGITUDINAL STUDY
0664 THE EFFECT OF SUMATRIPTAN ON THE UTERINE CONTRACTILITY OF HUMAN MYOMETRIUM
0665 SINGLE VERSUS MULTIPLE DOSES OF GENTAMICIN IN THE TREATMENT OF PYELONEPHRITIS DURING PREGNANCY: A RANDOMIZED CONTROLLED TRIAL
0666 CHOLESTASIS OF PREGNANCY MANAGED EXPECTANTLY IS NOT ASSOCIATED WITH ADVERSE FETAL OUTCOME: A COMPARATIVE STUDY OF 89,135 PATIENTS
0667 DIFFERENCE IN BIRTH WEIGHT CANNOT BE USED TO PREDICT SUCCESS/FAILURE OF VBAC ATTEMPTS AMONG THOSE WITH A PRIOR CESAREAN SECTION FOR CEPHALOPELVIC DISPROPORTION
0668 COMPARISON OF EARLY AND DELAYED FEEDING POST–CESAREAN DELIVERY
0669 CESAREAN DELIVERY FOR EXTREMELY LOW–BIRTH–WEIGHT INFANTS 500 TO 750 GRAMS IN BREECH PRESENTATION: WHAT ARE THE BENEFITS?
0670 BREECH PRESENTATION IN PRIMIPAROUS WOMEN: IS VAGINAL DELIVERY SAFE?
0671 ASSESSMENT OF RISK WITH TRANSABDOMINAL CERCLAGE
0672 FACTORS ASSOCIATED WITH SEVERE PERINEAL LACERATIONS IN WOMEN UNDERGOING OPERATIVE VAGINAL DELIVERY
0673 MATERNAL ANTHROPOMETRIC EFFECTS ON THE SUCCESS RATES OF EXTERNAL CEPHALIC VERSION

© 2000  Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

    •

  • Contenu

    •

Vol 184 - N° 1

P. S163-S195 - janvier 2001 Retour au numéro
Article précédent Article précédent
  • POSTER SESSION IV Friday, February 9, 2001, 3:30 pm – 5:30 pm
| Article suivant Article suivant
  • Subject index

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.

Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.